Campylobacter gastroenteritis associated with Sweet's syndrome.
Sweet's syndrome or acute febrile neutrophilic dermatosis has been associated with underlying infection, malignancy, inflammatory disease and certain medications. The infection agents associated with this include Streptococcus species, Yersinia species, Chlamydia species, Salmonella species and Helicobacter pylori. We report a case of Sweet's syndrome in a 73-year-old woman following a 2 week course of severe gastroenteritis caused by Campylobacter species. Histological examination of skin lesions showed marked inflammatory infiltrate throughout the dermis, composed of neutrophils and histiocytes. The patient was successfully treated with topical and systemic steroids. To date, this is the first case of Sweet's syndrome to be reported linked to Campylobacter species to our knowledge.
Clinical Microbiology & Public Health Laboratory, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Sumita
S
Pai
Department of Histopathology, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Ed
E
Rytina
Department of Dermatology, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Jane
J
Sterling
Clinical Microbiology & Public Health Laboratory, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
J A
JA
Karas
Clinical Microbiology & Public Health Laboratory, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
S H
SH
Aliyu
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002169:Campylobacter Infections / Q000150:complications* / Q000188:drug therapy; D002939:Ciprofloxacin / Q000627:therapeutic use; D002990:Clobetasol / Q000627:therapeutic use; D005260:Female; D005759:Gastroenteritis / Q000150:complications / Q000382:microbiology*; D006801:Humans; D011239:Prednisolone / Q000627:therapeutic use; D016463:Sweet Syndrome / Q000150:complications* / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D002939:Ciprofloxacin; D011239:Prednisolone; D002990:Clobetasol